Skip to main content
Livermore
Livermore
ZHEN

Renaissance Technologies LLC

SEC CIK
0001037389
Latest filing
Aug 13, 2026

CDTX holding history

Cidara Therapeutics, Inc. in every 13F filed by Renaissance Technologies LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

CDTX overviewAll 13F holders of CDTXFull Q2 2026 holdings

Shares (Q1 2026)
0
Sold out in Q1 2026
Value
$0
% of portfolio
0.0%
Quarters held
20
Since Q1 2021
Holdings of CDTX by Renaissance Technologies LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q1 20260$00.0%−110,560−100.0%Sold outHolders
Q4 2025110,560$24.4M<0.1%+6,300+6.0%AddedHolders
Q3 2025104,260$9.98M<0.1%−52,517−33.5%ReducedHolders
Q2 2025156,777$7.64M<0.1%+64,260+69.5%AddedHolders
Q1 202592,517$1.99M<0.1%−3,100−3.2%ReducedHolders
Q4 202495,617$2.57M<0.1%−2,200−2.2%ReducedHolders
Q3 202497,817$1.05M<0.1%+2,300+2.4%AddedHolders
Q2 202495,517$1.14M<0.1%−32,232−25.2%ReducedConverted for a 1-for-20 splitHolders
Q1 20242,554,973$2.35M<0.1%+752,800+41.8%AddedHolders
Q4 20231,802,173$1.43M<0.1%+202,500+12.7%AddedHolders
Q3 20231,599,673$1.51M<0.1%+50,100+3.2%AddedHolders
Q2 20231,549,573$1.75M<0.1%+292,800+23.3%AddedHolders
Q1 20231,256,773$1.60M<0.1%+71,400+6.0%AddedHolders
Q4 20221,185,373$896.0K<0.1%−107,900−8.3%ReducedHolders
Q3 20221,293,273$812.0K<0.1%+137,016+11.8%AddedHolders
Q2 20221,156,257$565.0K<0.1%−281,588−19.6%ReducedHolders
Q1 20221,437,845$1.20M<0.1%+23,588+1.7%AddedHolders
Q4 20211,414,257$1.80M<0.1%+293,996+26.2%AddedHolders
Q3 20211,120,261$2.51M<0.1%+73,958+7.1%AddedHolders
Q2 20211,046,303$2.11M<0.1%+237,800+29.4%AddedHolders
Q1 2021808,503$2.15M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.